Navigation Links
Scioderm, Inc. Named a 2013 "Fierce Top 15" Company by FierceBiotech
Date:9/24/2013

the world for its annual Fierce 15 list, which is based on a variety of factors such as the strength of its technology, partnerships, venture backers and a competitive market position.

A complete list of "Fierce 15" companies – the online newsletter's eleventh annual selection – is available online at FierceBiotech.com.

About Scioderm

Scioderm is a privately held, clinical-stage pharmaceutical company focused on developing innovative therapies to address critical medical needs in the treatment of rare diseases.  Scioderm's main focus is the treatment of Epidermolysis Bullosa (EB).  SD-101, its leading therapy for the treatment of skin effects in patients with Epidermolysis Bullosa, is currently in clinical trials. SD-101 is a topical cream that has previously demonstrated potential to provide improvement in treating the severe skin effects seen in patients across all EB subtypes.   Additional information about Scioderm can be found at www.sderm.com.

About FierceBiotech

FierceBiotech is the biotech industry's daily monitor – a free email newsletter and web resource providing the latest biotech news, articles, and resources related to clinical trials, drug discovery, FDA approval and regulation, biotech company deals and more. More than 90,000 top biotech professionals rely on FierceBiotech for an insider briefing on the day's top stories. Signing up is free.

Company Contact

Robert Coull
Chief Operating Officer
robert.coull@sderm.com
(919)-824-2594 


'/>"/>
SOURCE Scioderm
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Moderna Therapeutics Named a "Fierce 15" Biotech Company for 2013
2. TriCore Reference Laboratories Named First Next-Generation Sequencing Center of Excellence by Life Technologies
3. Andresen, McManamon, Willner Named Winners of SPIE Directors' and President's Awards
4. Luke Bradshaw Named CryoScience Global Marketing & Sales Manager for the Americas at Taylor-Wharton
5. Express Diagnostics Named to the Inc. 5000 List of Fastest-Growing Companies
6. Bayer CropScience Cotton Belt Challenge Winners Named
7. SynteractHCR Senior Director of Clinical Operations Mary Clegg Named One of the PharmaVOICE 100 Most Inspiring People in Life Sciences
8. Core and More Technologies Named Among Top 10 Best Internet Marketing Agencies in U.S.
9. Newlight Named Most Innovative Company of the Year
10. BioLife Solutions Named One of Washingtons Best Companies
11. Syngentas Mary-Dell Chilton named 2013 World Food Prize laureate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... PMG Research, Benchmark Research, and ... formation of VaxCorps, a network of highly experienced, ... conduct of vaccine trials in healthy adult, elderly, ... successfully conducted over 500 phase I-III vaccine clinical ... influenza as well as a vast array of ...
(Date:3/30/2015)... 30, 2015  NuGene International, Inc. ("NuGene") (OTCQB: ... BioPharma, Inc. has added another internationally recognized researcher ... is an internationally recognized researcher in bio-inspired materials ... at Peking University, China , ... University of North Carolina, Chapel Hill. Following a ...
(Date:3/30/2015)... ROCKVILLE, Md. , March 30, 2015 ... company dedicated to the acquisition, development and commercialization of ... for the global market with a commercial focus on ... China Food and Drug Administration (CFDA) has approved the ... trial in ovarian clear cell carcinoma (OCCC) patients for ...
(Date:3/30/2015)... Md. , March 30, 2015  Spherix ... company committed to the fostering and monetization of ... v. VTech,  Case No. 3:13-cv-03494-M and  Spherix v. ... United States District Court for the Northern District ... update regarding Spherix v. Verizon, Case ...
Breaking Biology Technology:PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 3
... CITY, Calif., Sept. 6, 2011 Pearl Therapeutics was named ... , designating it as one of the most promising private ... Fierce 15 selection. "Pearl,s veteran team has done ... research to advance PT003 – an inhaled LAMA/LABA combination therapy ...
... SINGAPORE, Sept. 6, 2011 ImaginAb, Inc. is pleased ... subsidiary, ImaginAb Molecular Imaging Pte Ltd (IMI). IMI is ... marks a significant increase in research capability for the ... molecular imaging services to both the US parent company ...
... Mass. and TORONTO, Sept. 6, 2011 Generex Biotechnology ... as part of the Company,s reorganization plan and following ... concomitant needs assessment, the Company has completed the sales ... net cash proceeds of just over $1,000,000.  The tenanted ...
Cached Biology Technology:FierceBiotech Names Pearl Therapeutics a 2011 Fierce 15 Biotech 2FierceBiotech Names Pearl Therapeutics a 2011 Fierce 15 Biotech 3ImaginAb, Inc. Announces Formation of Singapore Subsidiary, ImaginAb Molecular Imaging Pte Ltd. 2Generex Augments Cash Position With Sales of Non-Essential Assets 2Generex Augments Cash Position With Sales of Non-Essential Assets 3
(Date:3/18/2015)... CORAL SPRINGS, Florida , March 18, 2015 ... as well as businesses, new revolutionary smart wallets and apps ... rapid pace.  Companies currently entrenched in the mobile payment industry ... ), Alibaba Group Holding Ltd. (NYSE: BABA ), ... GOOG ) and Facebook Inc. (NASDAQ: ...
(Date:3/16/2015)... HANOVER, Germany , March 16, 2015 /PRNewswire/ ... DERMALOG Identification Systems GmbH will present groundbreaking innovations ... Hanover, Germany . ... DERMALOG,s latest biometric innovation is well at ... the next generation e-gate made in ...
(Date:3/12/2015)... MOUNTAIN VIEW, Calif. , March 12, 2015 ... EDTLOCATION:Online, with Complimentary Registration here: http://bit.ly/1G7Os0L . ... Program Manager Aravind SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 ... future in order to compete in several different ... the market is currently witnessing an uptrend. ...
Breaking Biology News(10 mins):Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3
... HOUSTON (March 12, 2010) Calculations are fine, ... paper by Rice University students who decided to put to ... In 1908, the German physicist Gustav Mie came up ... of electromagnetic waves with a spherical metal particle. The theory ...
... , PITTSBURGH Carnegie Mellon University,s Matt Oberdier is developing a new hydrosurgery ... ... Mellon, said his system will be designed to help surgeons readily clear ... ...
... The usual excuse of "lack of time" for not ... in The Journal of Physiology . The ... growing evidence for the benefits of short term high-intensity interval ... types of moderate long term exercise. Astonishingly, it is possible ...
Cached Biology News:Look at Mie! 2The new exercise HIT: do less 2
DITHIOTHREITOL, 150UMOL, 1 EA. Dithiothreitol (DTT), 0.1 M Solution:, *0.1 M solution of DTT in high purity dH2O., *0.2 m filtered., *Storage: -20C. Category: SEQUENASE....
GOAT ANTI HUMAN PARAINFLUENZA VIRUS 2+3...
75 x 25 mm; sterile, recommended for immunohistochemistry of cell lines growing in suspension, Poly-D-Lysine coated, glass slides with polystyrene vessel, lid and safety removal tool...
ANTI 5-HYDROXYTRYPTOPHAN CONJ....
Biology Products: